JP2008150352A - Sleep-improving agent composition - Google Patents

Sleep-improving agent composition Download PDF

Info

Publication number
JP2008150352A
JP2008150352A JP2006357279A JP2006357279A JP2008150352A JP 2008150352 A JP2008150352 A JP 2008150352A JP 2006357279 A JP2006357279 A JP 2006357279A JP 2006357279 A JP2006357279 A JP 2006357279A JP 2008150352 A JP2008150352 A JP 2008150352A
Authority
JP
Japan
Prior art keywords
sleep
glycine
theanine
aminobutyric acid
improving agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006357279A
Other languages
Japanese (ja)
Inventor
Masaki Gen
優基 玄
Yoko Gen
洋子 玄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MG SEIYAKU KK
Original Assignee
MG SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MG SEIYAKU KK filed Critical MG SEIYAKU KK
Priority to JP2006357279A priority Critical patent/JP2008150352A/en
Publication of JP2008150352A publication Critical patent/JP2008150352A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a sleep-improving agent composition in which persons suffering from insomnia can be safely used on a daily basis without risk of side effect. <P>SOLUTION: The sleep-improving agent composition comprises glycine, γ-aminobutyric acid and theanine. According to the present invention, sleep improvement effects such as improvement of hypnagogic retardation, decrease of arousal during sleep and improvement of sleep efficiency can be expected. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、グリシンとγアミノ酪酸、及びテアニンを含有する睡眠改善剤組成物、該組成物を含有する飲食品または医薬品、ならびに前記飲食品または医薬品の製造のためのグリシンとγアミノ酪酸、及びテアニンの混合物の使用に関する。  The present invention relates to a sleep-improving agent composition containing glycine and γ-aminobutyric acid and theanine, a food or drink or pharmaceutical containing the composition, and glycine and γ-aminobutyric acid for producing the food or drink or pharmaceutical, and It relates to the use of a mixture of theanine.

ヒトの成人は乳幼児の短い眠りを終日繰り返す睡眠様式と異なり、日中は覚醒しており夜間に集中的に睡眠をとる生活習慣を繰り返している。このような生活リズムは体内でのさまざまな物質が調整機能を果たしている。
人類の日常生活において食欲、性欲並びに睡眠欲の3つの欲が健康維持に重要である。近年、文明社会の到来とともにストレス社会へと移行し、睡眠に問題を感じているヒトは5人に1人以上であるといわれて、生活の質や健康維持のため睡眠に対する関心が日に日に高まってきている。
Unlike the sleep pattern in which a short sleep of an infant is repeated throughout the day, human adults are awake during the day and repeat the lifestyle of sleeping intensively at night. Such life rhythm is regulated by various substances in the body.
In the daily life of human beings, the three desires of appetite, libido and sleep are important for maintaining health. In recent years, with the advent of civilized society, it has been said that there is more than one in five people who are experiencing sleep problems, and their interest in sleep is increasing day by day to maintain quality of life and health. Is growing.

最近、食品よる睡眠改善の試みとしてアミノ酸を用いた報告がされている。例えば、特許文献1、特許文献2では、生体内で合成され最も単純な化学構造を有するアミノ酸であるグリシンをいびき又は睡眠時の呼吸障害の予防・緩和作用を有し、いびき又は睡眠時の呼吸障害の予防・緩和のために用いるものである旨の表示を付した食品が報告されている。また、特許文献3では、茶の葉に含まれているグルタミン酸誘導体であるテアニンを主成分とする睡眠改善用組成物、該組成物を含有する飲食品または医薬品、テアニンを用いる睡眠改善方法、ならびに前記飲食品または医薬品が報告されている。また、同じく特許文献4では、アミノ酸の一種類である、γアミノ酪酸(GABA)を用いた精神的疲労改善に関する報告もある。また、特許文献5には、睡眠改善効果を有するビタミン12に、安定剤としてのビタミCと、グリシンとを配合することが記載されている。さらに、特許文献6には「不眠症用組成物」として、バレリアンエキスと、鎮静作用を有するホップと、γアミノ酪酸(GABA)を高度に含有している米胚芽抽出物との組み合わせを用いることが記載されており、これにテアニンを配合できるとされている。しかし、上述のようなアミノ酸単品、もしくはビタミン類の配合剤では睡眠改善効果に乏しく、より効果的な睡眠改善組成物が望まれており、本発明のようなグリシンとγアミノ酪酸、及びテアニンの3成分を配合した睡眠改善剤組成物は報告されていない。
特開2006−191933号 国際公開WO2004/10098号 特開2005−289948号 特開2006−273733号 特開2006−169221号 特開2003−183174号
Recently, there have been reports using amino acids as an attempt to improve sleep by food. For example, in Patent Document 1 and Patent Document 2, glycine, which is an amino acid synthesized in the living body and having the simplest chemical structure, has an effect of preventing or alleviating breathing disorders during snoring or sleep. Foods with a label indicating that they are used to prevent or mitigate disabilities have been reported. Further, in Patent Document 3, a sleep improving composition mainly composed of theanine which is a glutamic acid derivative contained in tea leaves, a food or drink or pharmaceutical containing the composition, a sleep improving method using theanine, and The food or beverage or medicine has been reported. Similarly, Patent Document 4 also reports on mental fatigue improvement using γ-aminobutyric acid (GABA), which is one type of amino acid. Patent Document 5 describes that vitamin C having a sleep improving effect is blended with vitamin C as a stabilizer and glycine. Furthermore, Patent Document 6 uses a combination of a valerian extract, a hop having a sedative action, and a rice germ extract highly containing γ-aminobutyric acid (GABA) as an “insomnia composition”. It is said that theanine can be added to this. However, a combination of amino acid alone or vitamins as described above has a poor sleep improvement effect and a more effective sleep improvement composition is desired, and glycine, γ-aminobutyric acid, and theanine of the present invention are desired. No sleep improver composition containing three components has been reported.
JP 2006-191933 A International Publication WO2004 / 10098 JP-A-2005-289948 JP 2006-273733 A JP 2006-169221 A JP 2003-183174 A

発明が解決しようとする課題、及び、課題を解決する為の手段Problems to be solved by the invention and means for solving the problems

上記課題を解決するため、本発明者らは鋭意研究を重ねた結果、グリシンとγアミノ酪酸、及びテアニンの混合物がグリシンとγアミノ酪酸、及びテアニンの単品よりも遥かに睡眠改善効果に有効であり、数多い睡眠障害の項目における原因のうち、その睡眠改善効果が疲労感を軽減させ、起床時の睡眠時間が延長したと感じる、入眠改善、夢みの改善または中途覚醒の減少によるものであることを見出し、本発明を完成するに至った。  In order to solve the above-mentioned problems, the present inventors have conducted extensive research. As a result, a mixture of glycine, γ-aminobutyric acid, and theanine is far more effective in improving sleep than glycine, γ-aminobutyric acid, and theanine alone. Yes, among many causes of sleep disorders, the sleep improvement effect reduces fatigue and extends sleep time when waking up. As a result, the present invention has been completed.

発明の効果The invention's effect

本発明の睡眠改善剤組成物(以下、組成物)は、種々の原因により生ずる様々な睡眠障害を緩和又は改善することを目的として日常的に使用することができる。本発明の組成物によれば、睡眠障害における少なくとも1つ以上の症状を改善することができる。特に睡眠障害における「入眠改善」、「中途覚醒の減少」、「睡眠後半の中途覚醒の減少」、「睡眠効率の改善」からなる群より選ばれる少なくとも1つ以上の症状を効果的に改善することができる。本発明の組成物の作用の所望の効果の発現は、グリシンとγアミノ酪酸、及びテアニンを含有する組成物の相乗効果について初めて見出された睡眠改善効果に基づくものである。  The sleep-improving agent composition of the present invention (hereinafter, composition) can be used on a daily basis for the purpose of alleviating or improving various sleep disorders caused by various causes. According to the composition of the present invention, at least one symptom in sleep disorder can be improved. In particular, it effectively improves at least one symptom selected from the group consisting of “improving falling asleep”, “reducing mid-wakefulness”, “reducing mid-wakefulness in the latter half of sleep”, and “improving sleep efficiency” in sleep disorders. be able to. The expression of the desired effect of the action of the composition of the present invention is based on the sleep improvement effect first found for the synergistic effect of the composition containing glycine, γ-aminobutyric acid, and theanine.

発明を実施する為の最良の形態BEST MODE FOR CARRYING OUT THE INVENTION

本発明に用いられるグリシンは食品や化粧品として古くから用いられているアミノ酸の一つである。このグリシンとは、最も簡単な構造の非必須アミノ酸で、動物性タンパク質中に比較的多く含まれており、抗菌・酸化防止、キレート作用、緩衝作用などがあるため、食品添加物として用いられたり、化粧品に用いられる。
グリシンは、脳幹や脊髄における抑制性の神経伝達物質であることが知られていたが、2004年には、睡眠の質を左右するものであることが明らかになり、このグリシンが足りていると、短時間でもぐっすり眠れると言われている。最近、このグリシンの睡眠を改善する機能の研究が活発に進められ、神経伝達物質として中枢と末梢神経系で重要な役割を果たしていることが明らかにされつつあるが、複雑な睡眠覚醒調節機構は未だに解明されていない。
Glycine used in the present invention is one of amino acids that has been used for a long time as food and cosmetics. This glycine is the simplest non-essential amino acid that is relatively abundant in animal proteins and has antibacterial and antioxidant properties, chelating action, buffering action, etc., so it can be used as a food additive. Used in cosmetics.
Glycine was known to be an inhibitory neurotransmitter in the brainstem and spinal cord, but in 2004, it was revealed that it affects the quality of sleep. It is said that you can sleep well even in a short time. Recently, research on the function of glycine to improve sleep has been actively carried out, and it has been clarified that it plays an important role in the central and peripheral nervous system as a neurotransmitter. It has not yet been elucidated.

また、テアニンとは、茶の葉に含まれているグルタミン酸誘導体で、茶の旨味の主成分であって、呈味を用途とする食品添加物として使用されているアミノ酸である。
テアニンとリラックス、テアニンと眠りの関係の研究は、近年急速に進すみ脳のα波を増加させ脳・神経機能に作用して、興奮を抑え、心身をリラックスにさせる効果を与えることが明らかにされている。また、テアニンを摂取した場合、睡眠中に覚醒する時間が減少し睡眠の質を改善する効果が認められ、生理活性の点からも注目されている。
Theanine is a glutamic acid derivative contained in tea leaves, which is an amino acid that is the main ingredient of the umami of tea and is used as a food additive for the purpose of taste.
Research on the relationship between theanine and relaxation, and theanine and sleep has been shown to increase the alpha wave of the brain rapidly in recent years and act on the brain and nerve function to suppress excitement and relax the mind and body Has been. In addition, when theanine is ingested, the effect of improving the quality of sleep by reducing the awakening time during sleep is recognized, and is also attracting attention from the viewpoint of physiological activity.

さらに、本発明におけるγアミノ酪酸(GABA)とは、特に限定するものではないが、野菜、果物、穀物などから抽出されたγアミノ酪酸、発酵法により生産されたγアミノ酪酸、有機合成から生産されたγアミノ酪酸のことをいう。
GABAは生体内特に脳内に広く分布されている事が知られており、抑制系の神経伝達物質として知られている。しかし、GABAは血液脳関門を通過しないと言われており、従って経口で摂取したGABAによって、脳中枢神経系におけるGABA遊離量は通常影響しないとされ、最近このGABAがアルファ波を効果的に増強し同時にベータ波を積極的に減少させることにより「癒し状態」をもたらすことが報告されている。しかし、このGABAを睡眠改善剤として用いる検討はされていない。
Further, γ-aminobutyric acid (GABA) in the present invention is not particularly limited, but γ-aminobutyric acid extracted from vegetables, fruits, cereals, etc., γ-aminobutyric acid produced by fermentation method, produced from organic synthesis Refers to γ-aminobutyric acid produced.
GABA is known to be widely distributed in vivo, particularly in the brain, and is known as an inhibitory neurotransmitter. However, it is said that GABA does not cross the blood-brain barrier, and therefore GABA release in the brain central nervous system is not normally affected by GABA taken orally, and recently GABA effectively enhanced alpha waves. At the same time, it has been reported that a “healing state” is brought about by actively reducing beta waves. However, the use of this GABA as a sleep improving agent has not been studied.

以上のように、グリシンとγアミノ酪酸、及びテアニンの各単品については睡眠改善効果や癒し効果などが報告されているものの、本発明のようにグリシンとγアミノ酪酸、及びテアニンの2種もしくは3種類の混合組成の睡眠改善効果に関しては全く知られていなかった。  As described above, although each of glycine, γ-aminobutyric acid, and theanine has been reported to have a sleep-improving effect and a healing effect, glycine, γ-aminobutyric acid, and theanine are used in two or three types as in the present invention. It was not known at all about the sleep improvement effect of the mixed composition of various kinds.

本発明に用いられるグリシンとγアミノ酪酸、及びテアニンの安全性は高く、たとえば、マウスを用いた急性毒性試験においてそれぞれの組成物は、5g/kg経口投与で死亡例がなく異常は認められない。また、呈味を用途とする食品添加物としても使用され、食品衛生法上、その添加量に制限はない。しかも、従来の薬物と異なり、グリシンとγアミノ酪酸、及びテアニンによる副作用は全く認められないので、本発明の組成物によれば、安全かつ効果的に睡眠改善剤組成物として使用できる。
本発明の睡眠改善剤におけるグリシンとγアミノ酪酸、及びテアニンの配合量は、その種類によって異なるため、一概には言えないが、催眠効果を増強するための成人1回当たりの投与量は、おおよそ0.1μg〜3.0gの範囲であるので、これに対応した量とすれば良い。
The safety of glycine, γ-aminobutyric acid, and theanine used in the present invention is high. For example, in an acute toxicity test using mice, each composition has no death in oral administration of 5 g / kg and no abnormality is observed. . Moreover, it is used also as a food additive for the purpose of taste, and there is no restriction | limiting in the addition amount on Food Sanitation Law. Moreover, unlike conventional drugs, no side effects due to glycine, γ-aminobutyric acid, and theanine are observed, and therefore the composition of the present invention can be used safely and effectively as a sleep improving agent composition.
The blending amounts of glycine, γ-aminobutyric acid, and theanine in the sleep-improving agent of the present invention vary depending on the type of the sleep-improving agent. Therefore, it cannot be generally stated, but the dose per adult for enhancing the hypnotic effect is approximately Since it is the range of 0.1 microgram-3.0g, what is necessary is just to set it as the quantity corresponding to this.

具体的には、例えば成人1回当たりの投与量は、通常5〜3000mgの範囲にあり、好ましくは25〜2000mgであり、更に好ましくは50〜500mgであるので、これに対応した量を睡眠改善剤に配合すればよい。
本発明における睡眠改善効果を発揮されるグリシンの摂取量は平均体重60kgのヒトで2〜3gが好ましく、またテアニンの場合0.01mg/kg好ましくは1mg/kg体重から50mg/kg体重である。さらに、GABAは平均体重60kgのヒトで100〜500mg/日が好ましい。
Specifically, for example, the dose per adult is usually in the range of 5 to 3000 mg, preferably 25 to 2000 mg, and more preferably 50 to 500 mg. What is necessary is just to mix | blend with an agent.
The intake of glycine that exerts the sleep improving effect in the present invention is preferably 2 to 3 g for a human having an average body weight of 60 kg, and in the case of theanine, 0.01 mg / kg, preferably 1 mg / kg to 50 mg / kg body weight. Furthermore, GABA is preferably 100 to 500 mg / day for a human having an average weight of 60 kg.

本発明品である睡眠改善剤組成物を食品として摂取するにはグリシンとγアミノ酪酸、及びテアニンの混合物をそのまま、または、グリシンとγアミノ酪酸、及びテアニン混合物を含有する乾燥食品、サプリメント、また、清涼飲料やミネラルウォーター、嗜好飲料、アルコール飲料などの液状食品、錠剤、カプセル、粉末剤、顆粒剤、ドリンク剤等の種々の剤形で用いることが出来る。  In order to ingest the sleep-improving agent composition of the present invention as a food, a mixture of glycine and γ-aminobutyric acid and theanine is used as it is, or a dried food or supplement containing glycine, γ-aminobutyric acid and theanine mixture, or It can be used in various dosage forms such as liquid foods such as soft drinks, mineral water, taste drinks, alcoholic drinks, tablets, capsules, powders, granules, drinks and the like.

本発明の睡眠改善剤組成物は、上述した成分のほかに、賦形剤、乳化剤、安定剤、甘味料、pH調整剤、増粘剤、タンパク質、ペプチド、アミノ酸、脂質、多糖類、オリゴ糖等の通常食品に用いられる成分を含んでいてもよい。  In addition to the components described above, the sleep-improving agent composition of the present invention includes excipients, emulsifiers, stabilizers, sweeteners, pH adjusters, thickeners, proteins, peptides, amino acids, lipids, polysaccharides, oligosaccharides. Ingredients commonly used in foods such as

本発明の睡眠改善剤組成物はグリシンとγアミノ酪酸、及びテアニンの3成分、またはグリシンとγアミノ酪酸の2成分、もしくはグリシンとテアニンの2成分から構成されている。したがって、主成分はグリシンであり、そこにγアミノ酪酸、及びテアニンが混合されそれらの相乗効果が発揮されるのである。  The sleep-improving agent composition of the present invention comprises three components of glycine and γ-aminobutyric acid and theanine, or two components of glycine and γ-aminobutyric acid, or two components of glycine and theanine. Therefore, the main component is glycine, and γ-aminobutyric acid and theanine are mixed therewith and their synergistic effect is exhibited.

グリシンは睡眠持続効果があるものの入眠効果に欠け、またγアミノ酪酸とテアニンは逆に入眠効果があるものの睡眠持続効果が不足している。  Although glycine has a sleep-sustaining effect, it lacks a sleep-sleeping effect. On the other hand, γ-aminobutyric acid and theanine have a sleep-sleeping effect but lack a sleep-sustaining effect.

本発明の睡眠改善剤組成物におけるグリシンとγアミノ酪酸、及びテアニンの混合物の割合は特に制限はないが、グリシンが90〜99.9重量%、γアミノ酪酸が5〜0.01重量%、及びテアニンが5〜0.01重量%であるのが好ましい。  The ratio of the mixture of glycine, γ-aminobutyric acid, and theanine in the sleep-improving agent composition of the present invention is not particularly limited, but glycine is 90-99.9% by weight, γ-aminobutyric acid is 5-0.01% by weight, The theanine content is preferably 5 to 0.01% by weight.

上記の製剤化に使用される製剤添加剤としては、賦形剤、基剤、結合剤、崩壊剤、崩壊補助剤、滑沢剤、流動化剤、コーティング剤、可塑剤、消泡剤、糖衣剤、剤皮、光沢化剤、発泡剤、防湿剤、界面活性剤、可溶化剤、緩衝剤、溶解剤、溶解補助剤、溶剤、安定化剤、乳化剤、懸濁剤、分散剤、抗酸化剤、充填剤、粘稠剤、粘稠化剤、pH調整剤、防腐剤、保存剤、甘味剤、矯味剤、清涼化剤、着香剤・香料、芳香剤、着色剤などが挙げられる。  The formulation additives used in the above formulation include excipients, bases, binders, disintegrants, disintegration aids, lubricants, fluidizing agents, coating agents, plasticizers, antifoaming agents, sugar coatings Agent, skin, brightener, foaming agent, moisture proofing agent, surfactant, solubilizer, buffer, solubilizer, solubilizer, solvent, stabilizer, emulsifier, suspending agent, dispersant, antioxidant Agents, fillers, thickeners, thickeners, pH adjusters, preservatives, preservatives, sweeteners, flavoring agents, cooling agents, flavoring agents / fragrances, fragrances, colorants, and the like.

また、本発明の睡眠改善剤は1日数回に分けて服用できるが、1日1回就寝前に服用する形態であることが好ましい。  The sleep-improving agent of the present invention can be taken in several times a day, but it is preferably in a form that is taken once a day before going to bed.

以下、実施例、試験例により本発明を詳細に説明するが、本発明は当該実施例および試験例に限定するものではない。
本発明において、グリシンは味の素(株)製の“グリナ”を用いた。また、テアニンは太陽化学(株)製の“サンテアニン”を用いた。更にγアミノ酪酸は(株)ファーマフーズ製の“ファーマギャバ20−D”を使用した。
Hereinafter, although an example and a test example explain the present invention in detail, the present invention is not limited to the example and a test example concerned.
In the present invention, “Grina” manufactured by Ajinomoto Co., Inc. was used as glycine. As theanine, "Suntheanine" manufactured by Taiyo Kagaku Co., Ltd. was used. In addition, γ-aminobutyric acid used was “Pharmaca 20-D” manufactured by Pharma Foods.

グリシンとγアミノ酪酸、及びテアニンを含有する睡眠改善剤組成物を表1に示す組成物の割合で顆粒製剤を製造した。  A granule preparation was produced by using a sleep improving agent composition containing glycine, γ-aminobutyric acid, and theanine at a composition ratio shown in Table 1.

グリシンとγアミノ酪酸、及びテアニンを含有する睡眠改善剤組成物を表2に示す組成物の割合で顆粒製剤を製造した。  A granule preparation was produced in the proportion of the composition shown in Table 2 for the sleep improving agent composition containing glycine, γ-aminobutyric acid, and theanine.

グリシンとγアミノ酪酸、及びテアニンを含有する睡眠改善剤組成物を表3に示す組成物の割合で顆粒製剤を製造した。  A granule preparation was produced at a ratio of the composition shown in Table 3 to the sleep improving agent composition containing glycine, γ-aminobutyric acid, and theanine.

比較例1Comparative Example 1

グリシンとγアミノ酪酸、及びテアニンを含有する睡眠改善剤組成物の比較例としてグリシンのみでγアミノ酪酸、及びテアニンが入っていないグリシン単品製剤を用いた。  As a comparative example of the sleep-improving agent composition containing glycine, γ-aminobutyric acid, and theanine, a single glycine preparation containing only glycine and not containing γ-aminobutyric acid and theanine was used.

試験例1Test example 1

被験者は、通常の睡眠に問題を感じている男女ボランテイア10名(平均年齢42歳)であり、研究内容に関して十分な説明を受けた。  The test subjects were 10 male and female volunteers (average age 42 years old) who had problems with normal sleep, and received sufficient explanations regarding the research content.

試験例2Test example 2

実験期間中、被験者には通常の生活スタイルを心がけさせ、休日も勤務日とほぼ同じ就床時刻、起床時刻となるよう要請した。
実験スケジュールは、生活調整期間として3日、服用期間として実施例1のグリシンとγアミノ酪酸、及びテアニン混合顆粒剤、実施例2のグリシンとγアミノ酪酸、混合顆粒剤、実施例3のグリシンとテアニン混合顆粒剤、および比較例1の対照グリシン顆粒剤各6日とし、実施例1、2、ならびに実施例3のグリシンとγアミノ酪酸、及びテアニン混合顆粒剤および比較例1の対照錠剤間に1日間の効果消去期間をおいた。
During the experiment period, subjects were asked to keep their normal lifestyle, and the holidays were requested to have the same bedtime and wake-up time as work days.
The experimental schedule is 3 days as a life adjustment period, glycine and γ-aminobutyric acid and theanine mixed granule of Example 1 as a dosing period, glycine and γ-aminobutyric acid of Example 2, mixed granule, glycine of Example 3 The theanine mixed granule and the control glycine granule of Comparative Example 1 each 6 days, between the glycine and γ-aminobutyric acid of Examples 1 and 2 and Example 3, and the theanine mixed granule and the control tablet of Comparative Example 1 There was a one-day effect elimination period.

表4に試験結果を示す。  Table 4 shows the test results.

本発明により、日常的に睡眠不足に悩まされ、日中は疲労感と脱力感のため仕事はもちろんのこと日常生活にも不満足をきたしていた成人が、起床時にぐっすり寝たと感じ爽やかな朝を迎え、健康的な日々を迎えられることになる、睡眠改善剤の組成物を提供される。したがって、この組成物は種々の飲食品や医薬品として応用できる。

Figure 2008150352
Figure 2008150352
Figure 2008150352
Figure 2008150352
With the present invention, an adult who suffers from lack of sleep on a daily basis and feels tired and weak during the day and is dissatisfied not only with his work but also with his daily life, feels a good sleep when he gets up. A composition for improving sleep is provided that will greet and have healthy days. Therefore, this composition can be applied as various foods and beverages and pharmaceuticals.
Figure 2008150352
Figure 2008150352
Figure 2008150352
Figure 2008150352

Claims (4)

グリシンとγアミノ酪酸、及びテアニンを含有することを特徴とする睡眠改善剤組成物。A sleep improving agent composition comprising glycine, γ-aminobutyric acid, and theanine. 睡眠改善効果が入眠遅延改善、睡眠中の中途覚醒の減少、及び睡眠効率の改善などを特徴とする請求項1記載の睡眠改善剤組成物。The sleep-improving agent composition according to claim 1, wherein the sleep-improving effect is improved sleep delay, decreased arousal during sleep, and improved sleep efficiency. 組成物がグリシンとγアミノ酪酸、及びテアニンの3成分、またはグリシンとγアミノ酪酸の2成分、もしくはグリシンとテアニンの2成分から構成されている、即ち上記化合物の2種または3種類を配合することを特徴とする請求項1記載の睡眠改善剤組成物。The composition is composed of three components of glycine and γ-aminobutyric acid and theanine, or two components of glycine and γ-aminobutyric acid, or two components of glycine and theanine, that is, blending two or three of the above compounds The sleep-improving agent composition according to claim 1. グリシンとγアミノ酪酸、及びテアニンの混合割合は、グリシンが90〜99.9重量%、γアミノ酪酸が5〜0.01重量%、及びテアニンが5〜0.01重量%であることを特徴とする請求項1記載の睡眠改善剤組成物。The mixing ratio of glycine, γ-aminobutyric acid, and theanine is characterized in that glycine is 90-99.9% by weight, γ-aminobutyric acid is 5-0.01% by weight, and theanine is 5-0.01% by weight. The sleep improving agent composition according to claim 1.
JP2006357279A 2006-12-15 2006-12-15 Sleep-improving agent composition Pending JP2008150352A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006357279A JP2008150352A (en) 2006-12-15 2006-12-15 Sleep-improving agent composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006357279A JP2008150352A (en) 2006-12-15 2006-12-15 Sleep-improving agent composition

Publications (1)

Publication Number Publication Date
JP2008150352A true JP2008150352A (en) 2008-07-03

Family

ID=39652924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006357279A Pending JP2008150352A (en) 2006-12-15 2006-12-15 Sleep-improving agent composition

Country Status (1)

Country Link
JP (1) JP2008150352A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175773A1 (en) * 2013-04-25 2014-10-30 Pankratov Vasiliy Vasil Evich A formula for restoring normal sleep and biological rhythms
CN111802644A (en) * 2020-07-20 2020-10-23 花姐生物科技(杭州)有限公司 Food composition for improving sleep
KR20200129661A (en) * 2019-05-09 2020-11-18 주식회사 엠에이치투 바이오케미칼 Composition of food or pharmacy for inducing sleep of good quality
CN115024491A (en) * 2022-06-10 2022-09-09 百威(武汉)啤酒有限公司 Composition for assisting sleep and application thereof, beverage containing composition and preparation method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322053A (en) * 2001-04-24 2002-11-08 Taiyo Kagaku Co Ltd Composition for improving mental concentration
JP2003183174A (en) * 2001-12-19 2003-07-03 Fancl Corp Composition for insomnia
WO2005067738A1 (en) * 2004-01-14 2005-07-28 Ajinomoto Co., Inc. Glycine-containing food and use thereof
JP2005289948A (en) * 2004-04-06 2005-10-20 Taiyo Kagaku Co Ltd Sleep improvement composition
WO2005097101A1 (en) * 2004-04-06 2005-10-20 Taiyokagaku Co., Ltd. Sleep-improving composition
JP2006061088A (en) * 2004-08-27 2006-03-09 Pharma Foods International Co Ltd Concentration power-improving drink or food
JP2006169221A (en) * 2004-12-13 2006-06-29 Crescendo Corporation Sleeping supplement

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322053A (en) * 2001-04-24 2002-11-08 Taiyo Kagaku Co Ltd Composition for improving mental concentration
JP2003183174A (en) * 2001-12-19 2003-07-03 Fancl Corp Composition for insomnia
WO2005067738A1 (en) * 2004-01-14 2005-07-28 Ajinomoto Co., Inc. Glycine-containing food and use thereof
JP2005289948A (en) * 2004-04-06 2005-10-20 Taiyo Kagaku Co Ltd Sleep improvement composition
WO2005097101A1 (en) * 2004-04-06 2005-10-20 Taiyokagaku Co., Ltd. Sleep-improving composition
JP2006061088A (en) * 2004-08-27 2006-03-09 Pharma Foods International Co Ltd Concentration power-improving drink or food
JP2006169221A (en) * 2004-12-13 2006-06-29 Crescendo Corporation Sleeping supplement

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175773A1 (en) * 2013-04-25 2014-10-30 Pankratov Vasiliy Vasil Evich A formula for restoring normal sleep and biological rhythms
KR20200129661A (en) * 2019-05-09 2020-11-18 주식회사 엠에이치투 바이오케미칼 Composition of food or pharmacy for inducing sleep of good quality
KR102329246B1 (en) * 2019-05-09 2021-11-23 주식회사 엠에이치투 바이오케미칼 Composition of food or pharmacy for inducing sleep of good quality
CN111802644A (en) * 2020-07-20 2020-10-23 花姐生物科技(杭州)有限公司 Food composition for improving sleep
CN115024491A (en) * 2022-06-10 2022-09-09 百威(武汉)啤酒有限公司 Composition for assisting sleep and application thereof, beverage containing composition and preparation method

Similar Documents

Publication Publication Date Title
WO2018052020A1 (en) Sleep disorder improvement agent and method for improving sleep disorders
JPH0649647B2 (en) Human fourth stage sleep enhancer
KR20100094485A (en) Anti-fatigue agent comprising amino acid composition
EP3115047B1 (en) Debility preventative
WO2007066642A1 (en) Oral preparation for preventing or improving skin dryness
WO2014069660A1 (en) Blood flow promoting agent
JP2005097161A (en) Anti-fatigue composition and food containing the same
JP2008150352A (en) Sleep-improving agent composition
JP2008143811A (en) Lipid metabolism promoting composition
JP2008120754A (en) Antifatigue agent
EP2196099B1 (en) Immuno-nutritional composition
JP4914594B2 (en) Food composition for improving joint pain
JP2009013143A (en) Sleep-improving composition
JP2008088101A (en) Antifatigue agent
JP2005213185A (en) Energy-supplementary and anti-fatigue food and beverage
JP5394644B2 (en) Muscle enhancer containing asperroside or its analog
WO2013166246A2 (en) Formulation and method to induce a deep state of relaxation
CA2757351C (en) Anti-mental fatigue drug
JP2005097162A (en) Anti-fatigue composition containing glutamine peptide
JP6214628B2 (en) Oral composition
JP2008044885A (en) Composition for oral administration for fatigue prevention and preparation for oral administration for fatigue prevention
CN113491334B (en) nutritional composition
JP2008031080A (en) Lipid utilization-promoting composition
KR102428972B1 (en) Dietary composition for the prevention of obesity
JP6226962B2 (en) Non-REM sleep enhancer, deep sleep enhancer, natural sleep inducer, and early sleep delta power enhancer

Legal Events

Date Code Title Description
A621 Written request for application examination

Effective date: 20091214

Free format text: JAPANESE INTERMEDIATE CODE: A621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120828

A02 Decision of refusal

Effective date: 20130129

Free format text: JAPANESE INTERMEDIATE CODE: A02